Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

GSK antisense drug fails muscular dystrophy trial

Company and its partner Prosensa suffer setback with drisapersen

- PMLiVE

EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

Nine new branded medicines recommended for use in Europe

What did the iPad ever do for us?

Tablets are here to stay, but capitalising on them requires moments of ‘wow’

KaloBios names Herb Cross as CFO

He joins from Affymax

Roche Basel Switzerland

Roche: Keep Cancer Drugs Fund until VBP shown to work

Company says uncertainty remains about impact of new UK pricing system

- PMLiVE

Pharma firms ramp up Cancer Drugs Fund pressure

Novartis, Roche and Sanofi join forces to highlight public attitudes to medicines access

- PMLiVE

Generics industry pressures FDA over biosimilar naming standards

GPhA says biosimilars should carry same name as branded biologic medicines

Actelion HQ Switzerland

Actelion complete Ceptaris purchase

Follows approval of lymphoma gel product Valchlor

- PMLiVE

Double asthma approval in Japan lifts SkyePharma

Regulatory wins for company’s commercial partners GSK and Kyorin

- PMLiVE

Boehringer to work with Roche on cancer diagnostics

Will collaborate with Roche subsidiary Ventana Medical Systems

- PMLiVE

Owen Mumford appoints general manager for SEMEA

Eric Del Cotto to oversee operations of medical device firm in Southern Europe, Middle East and Africa

Merrill Brink pharmacovigilance

Pharmacovigilance and adverse event reporting: Five keys for establishing worldwide best practice

Pharmacovigilance, an arm of patient care with a charter to make the best use of medicines and data for the treatment or prevention of disease, is taking on growing importance...

Merrill Brink International

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links